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How did you get interested in biology?
John: I was always interested in animals. In Portugal, my most treasured books were about wildlife and I had the Jungle Book soundtrack on my little record player all the time. We also had quite the pet menagerie growing up, including German Shepherds and assorted mongrels, feral cats, hedgehogs, frogs, and ducks. Later I was a member of the Young Zoologists Club at London Zoo. Running along in parallel, however, was the desire to be a doctor. A school friend and I would go on frequent weekend pilgrimages to a medical bookshop, which has longsince closed, on Gower Street near University College Hospital in London. I can remember the reverence we felt for all those knowledge-heavy textbooks arrayed on dark shelves. This biology/medicine duality has never gone away. I spent my last year as an undergraduate in the Zoology department doing experiments on locomotion in the locust, nerve conduction in the worm, and DNA transcription in Xenopus oocytes, instructed by deep and original thinkers such as Malcolm Burroughs and John Gurdon. I then went on to medical school and residency in New York. During neurology residency I was drawn into the orbit of Columbia neuroscientist Claude Ghez who had trained in Italy in the grand physiological tradition with Pompeiano and Maffei: intellectual descendants of Sherrington, Granit, and Lundberg. Claude and I would have innumerable wide-ranging discussions over the years in which he taught me about diverse subjects ranging from the properties of muscle spindles to theories of the reaction time. Claude was (is) a hugely gifted experimentalist who transitioned over time from physiological studies in the cat to human psychophysics. He showed me how careful psychophysical experiments in healthy humans can reveal behavioral invariances, which provide clues as to how evolution designed the nervous systemspecifi cally, how the problem of action is decomposed into a hierarchical physiological and anatomical architecture with an attendant computational and algorithmic modularity.
David: I got interested in biology through the glimmer of an idea of life as an evolving computation. This derived from my early fascination with programming computers and the ridiculous idea that I shared with my nerdy friends, that we might create new life through simulation on an 8 bit 6502 processor. I was interested in the idea of what biology is before I was interested in biology itself. Physics always seemed rather obvious to me -the universe of particles, forces and fi elds. The living world is so much messier and odder, and frankly, incomprehensible. And the people practicing biology whom I read, Darwin, Linnaeus, Jacob, Darcy Thompson, were searching for ways of mapping this beautiful mess onto an underlying logic -taxonomical, algorithmic, and geometrical. John: I have three rather specifi c questions that relate to my current work. First, how does spontaneous biological recovery after stroke work, what can we do to amplify and prolong it in the acute stroke period, and how can it be turned on again in the chronic stroke period? Second, what exactly are the unique contributions of the motor cortex, the basal ganglia and the cerebellum to motor learning and motor control? I know some may think this question overly modular but I think it can still be usefully asked. Finally, I would like to know what practice is and why it takes such a long time to become an expert at anything. In the absence of an omniscient being, I will settle with teaming up with David on this last question, as I suspect this has as much to do with task complexity as it does with neural constraints.
What is wrong with science?
John: There is a LOT wrong, at least in biomedical research and neuroscience, areas in which I am in a position to speak. Perhaps I can partially convey the problem through reference to Milan Kundera's slim novel Slowness, written in 1995. At the beginning of the novel the narrator asks "Why has the pleasure of slowness disappeared?" In science, reading books, let alone writing them, is out. Imagine if a graduate student or post-doc were to say to their PI that they are off to the library to spend a few hours in quiet contemplation. The response would not be pretty.
A corollary of this crowding out of thought is of course the horror of the current system of scientifi c publication and the twisted academic incentive system with which it is locked in a death embrace. I recently heard a senior professor talk with excitement about speakers they had invited to a symposium because of how many publications they had. This lamentable state of affairs, in which the measurement (publications) becomes the goal rather than what is measured (good science), is an example of Goodhart's law, which was fi rst applied to economics: "As soon as the government attempts to regulate any particular set of fi nancial assets, these become unreliable indicators of economic trends." A related symptom of this absurd situation is requests for ever-speedier review of manuscripts, which is to be predicted when the publication itself rather than its content is what is valued. In other words, the science currently encourages production of ever-shorter fragments that must burn ever more brightly to get attention. The journals revel in this superfi ciality, with articles increasingly reading like a combination of a TED talk and a needlessly complicated cooking recipe. I struggle to articulate precisely the feeling that comes over me when I start to read a typical neuroscience article in a top-tier journal; a mild cognitive allergic reaction sets in. The reigning house style is almost designed to irritate: the disappearance of a starting hypothesis, the substitution of well-constructed arguments by a few gnomic sentences, the presentation of hopelessly intricate fi gures designed to hide rather than to reveal, and the concluding statement, simultaneously exaggeration and anti-climax.
My fi nal concern relates to the state of biomedical research, with its relentless belief that we will solve disease either one molecule or one gene at a time. The '-omic' phase we are in now is so over-hyped it is hard to know how to begin to describe the emperor's less than attractive naked body. Michael Joyner and John Ioannidis, among others, have written very perceptively about this problem. People are rightly worried about the state of the humanities but my brother and I are similarly worried about science, as it is crowded out by technology-worship and frenzied data collection.
David: I love science, implying doubt, uncertainty, experiment, theory, connections, mechanisms, prediction and understanding. Science is the most spectacularly disrespectful activity in the history of the world. It is a shock and probably a mistake that scientists are seen as respectable. At the same time science is hard, deliberative, and useful -it changes the world -for the better when coupled with sensible policies and when combined with a humanistic stance. As John puts it so well, today too much science has been derailed by short-term economic and R736 Current Biology 27, R731-R745, August 7, 2017 technological considerations, mutant professional incentives, territoriality fi tting of a medieval castle with mental moats, gates, and keeps, and a devastating disregard for historical and intellectual currents. It is high time we returned to our roots in radical, deep and irreverent scholarship of the sort discussed in the rich philosophical and historical work of Ian Hacking (Historical Ontology), Peter Galison (Image and Logic), and Steven Shapin and Simon Schaffer (Leviathan and the Air Pump).
How do you arrive at an interesting question?
John: Science is for me about unease and puzzlement, which can be triggered either by observations in the world or by the feeling that prevailing ideas are not quite right. This unease leads me to design new experiments or to contemplate alternative conceptual frameworks. For example, I decided to take another look at what consolidation of motor memory is, at what the patient HM actually taught us, and at the effi cacy of current neurorehabilitation. By nature I am a splitter, and like to break phenomena down into their more primitive component parts. I am wary of theories that prematurely see a single universal thing when there are lots of messy things. In a sense, I am a fox rather than a hedgehog in Isaiah Berlin's famous dichotomy. I think a question is interesting when it has richness in its particularity but the answer has a more general principle hiding in it.
David: The signature of an interesting question is complete and utter befuddlement, what John calls puzzlement. I am drawn to problems that are grounded in particularity and that suggest, through some subliminally intuitive hints, surprising generalities. Discomfort and unease is what I desire when I go to a talk -the opposite of boredom -and when I am pursuing the lead for an idea. I think of science the way that early naturalists might have thought about the world -full of frightening and unlikely organisms, each new encounter defying common sense. This feeling is captured by Darwin's remark that "It is diffi cult to believe in the dreadful but quiet war lurking just below the serene facade of nature." And the weirder the better, which leaves lots of room to reconcile multiple observations within lucid frameworks of some sort.
How important are the humanities and the arts for your science?
John: They have been and remain crucial to us both personally, but we also consider them central to the scientifi c enterprise itself. I am not alluding to the obvious fact that science is a cultural product and is therefore subject to ideologies that run along in parallel with its claims to objectivity. This is almost banal when stated as a generality but good scholarship on instances when prevailing fashions and ideas from outside of science infl uence science itself is both fascinating and important. One only has to think of the shameful relationship between racism and biology over the last two and half centuries.
In a short essay on Nabokov, the writer WG Sebald (a huge favorite of ours) states: "the most brilliant passages in his prose often give the impression that our worldly doings are being observed by some other species.." This is what we love about Nabokov and Melville, and other writers, lyrical naturalists observing us. Artists look out at the world, transform it and in doing so enhance our understanding of it. Is this not what scientists also do? Like David, I fi nd the divide between art and science pernicious and I suspect it comes, in part, from the belief that once things become formalized mathematically the fuzziness of art, which is expressed in images and words, is no longer needed. In my view this is profoundly wrong for biology -both with regard to how we think our way to scientifi c truths and the form in which we come to understand them. Also of great value is the fact that the academic units of the humanities are the extended essay and the book. These, in my view, are superior tools for thought than the typical short scientifi c paper. Having just co-authored a book, I have concluded that books through their length and organization demand extra complexity in one's scientifi c thinking.
David: We grew up reading books about physics, evolution, natural history, mathematical logic, and neuroscience. The gifts we gave each other for birthdays and Christmas were always books: fi ction, philosophy and science. Favorites include Jorge Luis Borges, Vladimir Nabokov, George Perec, Bertrand Russell, Martin Gardner, Raymond Smullyan, Ludwig Wittgenstein, Peter Medawar, Stephen Jay Gould, and Oliver Sacks. So naturally I am depressed by the idea of a world that is not rich in science, the humanities, and the arts. These are all representational endeavors -all seek to encode into abstraction some essential elements of reality. They fi nd and communicate patterns, and in so doing, render parts of perception comprehensible and in some special cases make our lives better. It is a terrible state of affairs that our educational system allows for such an extreme fragmentation of knowledge. When you consider the range of ideas and stylistic excellence of Newton, Darwin, Thompson, Einstein, Bohr, Poincare, not to speak of my colleague at SFI, Murray Gell-Mann, you see that they all read voraciously, they all grapple with very deep ideas and they accept that they can only make a professional contribution to a very small number of them. The fact that we are limited in time and ability should not make us limited in curiosity and culture. In both rodents and humans, IELs are classifi ed as 'natural'/thymic-derived IELs (nIELs) and as 'induced'/peripheral IELs (pIELs). nIELs are present at birth and belong to both the  and  T-cell lineages, which carry the  T-cell receptor (TCR) and  TCR, respectively. Conventional TCR + cells expressing the CD4 or CD8 surface molecules give rise to pIELs following exposure to tissue-derived antigens. In the intestine, both nIEL and pIEL populations acquire the expression of CD8 homodimers, which in mice bind both to classical major histocompatibility complex I (MHC-I) molecules and to non-classical MHC-I molecules that are associated with intestinal epithelial cells and decrease the antigen sensitivity of the TCR and negatively regulate T-cell activation.
Signifi cant differences in the abundance of each IEL population exist between mice and man. For instance, in mice the frequency of intestinal pIELs gradually increases with age, whereas the relative frequency of nIELs decreases. In humans, both nIELs and pIELs are thought to be present at birth and to maintain relatively stable frequencies during ageing.
Quick guide
Additionally, TCR + nIELs are much more frequent in mice than in humans, and the presence of TCR + nIELs has not been confi rmed in human tissues. In both mice and humans, CD8 + IELs outnumber CD4 + IELs, contrasting with the CD4:CD8 ratio of around 2:1 that is observed in peripheral blood and other non-epithelial tissues.
In which tissues are IELs present?
Although most work on IELs has been focused on the gut (Figure 1 ) and the skin, these cells can be found in the epithelium of all mucosal and barrier sites. In the gastro-intestinal tract, the proximal small intestine harbors the highest concentration of IELs, which gradually decreases towards the distal small intestine and colon. In the skin, IELs -in particular, tissueresident TCR + cells -are located in the epidermis. TCR + nIELs, CD4 + and CD8 + pIELs have also been described in the bronchi, sharing several characteristics with gut IELs, such as expression of the surface molecule CD103. Moreover, TCR + nIELs and CD4 + and CD8 + pIEL populations exist in the reproductive and genital tract of both males and females. Nevertheless, there are some key differences between tissues: for example, skin TCR + IELs (also known as dendritic epidermal T cells) display a myeloid morphology and are primarily sessile, whereas intestinal TCR + IELs display a lymphoid morphology and are highly motile. Additional studies are needed to defi ne if and how these differences translate to functional adaptation in each tissue.
How do IELs develop? T cells classically depend on an intrathymic stage for their differentiation, although nIELs have been proposed to develop extrathymically, given that they are present in athymic (so-called 'nude') mice. This observation triggered decades of debate regarding the possibility of thymus-independent nIEL development. In the past 10 years, studies have identifi ed thymic nIEL precursors that develop via 'agonist selection', whereby self-antigen recognition drives the differentiation of CD4 -CD8 -TCR + cells. These 'thymic IEL precursors' migrate directly to the intestinal epithelium without fi rst populating peripheral lymphoid organs. For TCR + cells, thymic selection does
